Lori Rudolph-Owen, PhD

Lori Rudolph-Owen, PhD

Chief Development Officer, Goldfinch Bio

As Chief Development Officer at Goldfinch Bio since 2018, Dr. Rudolph-Owen oversees the Company’s development organization, including clinical, regulatory, CMC, nonclinical and portfolio strategy. She brings over 20 years of leadership experience in pharmaceutical and biotechnology research and development, specifically in strategic portfolio planning and leadership, development operations and talent growth. Prior to Goldfinch, Rudolph-Owen served as the VP of Portfolio Management and Assessment at TESARO, Inc. She received her Ph.D. in Cell Biology at Vanderbilt University.

Back to Lori Rudolph-Owen, PhD